Heritage Investors Management Corp Has $2.68 Million Position in Walgreens Boots Alliance Inc (WBA)
Heritage Investors Management Corp grew its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 935.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 34,660 shares of the pharmacy operator’s stock after buying an additional 31,313 shares during the period. Heritage Investors Management Corp’s holdings in Walgreens Boots Alliance were worth $2,676,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also made changes to their positions in WBA. Hudock Capital Group LLC lifted its holdings in Walgreens Boots Alliance by 0.5% during the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after buying an additional 6 shares during the last quarter. Westside Investment Management Inc. lifted its holdings in Walgreens Boots Alliance by 10.4% during the 2nd quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock worth $102,000 after buying an additional 125 shares during the last quarter. IHT Wealth Management LLC lifted its holdings in Walgreens Boots Alliance by 46.3% during the 2nd quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock worth $135,000 after buying an additional 2,199 shares during the last quarter. Bristlecone Advisors LLC purchased a new stake in Walgreens Boots Alliance during the 3rd quarter worth about $135,000. Finally, Private Vista LLC lifted its holdings in Walgreens Boots Alliance by 6,403.7% during the 2nd quarter. Private Vista LLC now owns 583,185 shares of the pharmacy operator’s stock worth $140,000 after buying an additional 574,218 shares during the last quarter. 61.41% of the stock is owned by institutional investors.
Walgreens Boots Alliance Inc (WBA) opened at $71.94 on Friday. The stock has a market capitalization of $72,850.00, a PE ratio of 14.06, a P/E/G ratio of 1.28 and a beta of 1.22. Walgreens Boots Alliance Inc has a 52-week low of $63.82 and a 52-week high of $88.00. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.07 and a quick ratio of 0.59.
Walgreens Boots Alliance declared that its board has initiated a stock buyback program on Wednesday, October 25th that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the pharmacy operator to reacquire shares of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s management believes its stock is undervalued.
The business also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Monday, November 13th were given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 2.22%. The ex-dividend date was Friday, November 10th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 42.33%.
In other Walgreens Boots Alliance news, Director John Anthony Lederer bought 20,000 shares of the company’s stock in a transaction on Thursday, October 26th. The shares were bought at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the transaction, the director now owns 50,000 shares of the company’s stock, valued at approximately $3,350,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total value of $184,324.32. Following the transaction, the director now owns 16,415 shares in the company, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. Insiders own 14.80% of the company’s stock.
WBA has been the subject of several research reports. Deutsche Bank initiated coverage on Walgreens Boots Alliance in a report on Monday, December 4th. They issued a “hold” rating and a $78.00 target price for the company. Raymond James Financial reissued a “market perform” rating on shares of Walgreens Boots Alliance in a report on Wednesday, September 27th. BidaskClub raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Wednesday, August 30th. Leerink Swann downgraded Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating in a report on Wednesday, November 1st. Finally, Loop Capital set a $90.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a report on Thursday, October 26th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $86.47.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Stock Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related stocks with our FREE daily email newsletter.